Abstract
The overwhelming majority of head and neck malignancies are squamous cell carcinomas of the oral cavity, pharynx, and larynx. Three modalities of therapy have established roles in the treatment of carcinoma of the head and neck: chemotherapy, radiation therapy, and surgery. The choice of modality depends upon factors such as the site and extent of the primary lesion, the likelihood of complete surgical resection, the presence of lymph node metastases, and others. Traditionally, smaller lesions (T1–T2) are quite effectively treated by either surgical excision or irradiation, whereas more advanced cancers (stage III–IV) are treated with combined modalities. In recent years, chemoradiation has become an accepted alternative to surgery and postoperative radiation therapy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Richard JM, Kramar A, Molinari R, Lefebvre JL, Blanchet F, Jortay A, et al. Randomised EORTC head and neck cooperative group trial of preoperative intraarterial chemotherapy in oral cavity and oropharynx carcinoma. Eur J Cancer. 1991;27(7):821–7.
Kovács AF. Intra-arterial induction high-dose chemotherapy with cisplatin for oral and oropharyngeal cancer: long-term results. Br J Cancer. 2004;90(7):1323–8.
Kovács AF, Turowski B. Chemoembolization of oral and oropharyngeal cancer using a high-dose cisplatin crystal suspension and degradable starch microspheres. Oral Oncol. 2002;38(1):87–95.
Kovács AF. Chemoembolization using cisplatin crystals as neoadjuvant treatment of oral cancer. Cancer Biother Radiopharm. 2005;20(3):267–79.
Robbins KT, Kumar P, Harris J, McCulloch T, Cmelak A, Sofferman R, et al. Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multiinstitutional setting: results of Radiation Therapy Oncology Group Trial 9615. J Clin Oncol. 2005;23(7):1447–54.
Rasch CRN, Hauptmann M, Schornagel J, Wijers O, Buter J, Gregor T, et al. Intraarterial versus intravenous chemoradiation for advanced head and neck cancer: results of a randomized phase 3 trial. Cancer. 2010;116(9):2159–65.
Mendenhall WM, Riggs CE, Vaysberg M, Amdur RJ, Werning JW. Altered fractionation and adjuvant chemotherapy for head and neck squamous cell carcinoma. Head Neck. 2010 Jul;32(7):939–45.
Nishio R, Saito K, Ito H, Yoshida T, Kitamura K, Shimizu A, Kanesaka N, Mikami R, Hasegawa D, Suzuki M, Tokuuye K. Selective intraarterial chemoradiation therapy for oropharyngeal carcinoma with high-dose cisplatin. Jpn J Radiol. 2011 Oct;29(8):570–5.
Takayama K, Nakamura T, Takada A, Makita C, Suzuki M, Azami Y, Kato T, Hayashi Y, Ono T, Toyomasu Y, Hareyama M, Kikuchi Y, Daimon T, Mitsudo K, Tohnai I, Fuwa N. Treatment results of alternating chemoradiotherapy followed by proton beam therapy boost combined with intra-arterial infusion chemotherapy for stage III-IVB tongue cancer. J Cancer Res Clin Oncol. 2016 Mar;142(3):659–67.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Kovács, A.F. (2018). Head and Neck. In: Van Cutsem, E., Vogl, T., Orsi, F., Sobrero, A. (eds) Locoregional Tumor Therapy. Springer, Cham. https://doi.org/10.1007/978-3-319-69947-9_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-69947-9_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-69946-2
Online ISBN: 978-3-319-69947-9
eBook Packages: MedicineMedicine (R0)